Cargando…
Monitoring of gastrointestinal carcinoma via molecular residual disease with circulating tumor DNA using a tumor‐informed assay
BACKGROUND: Circulating tumor DNA (ctDNA)‐based minimal residual disease (MRD) detection, which can identify disease relapse ahead of radiological imaging, has shown promising performance. The objective of this study was to develop and validate OriMIRACLE S (Minimal Residual Circulating Nucleic Acid...
Autores principales: | Qi, Zining, Li, Yi, Wang, ZhengKun, Tan, Xuerong, Zhou, Yixuan, Li, Zhendong, Zhao, Weirong, Zheng, Xin, Yao, Jicheng, Li, Feng, Wang, Weifeng, Wang, Zhizheng, Pang, Fei, Wang, Gang, Gu, Weiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501225/ https://www.ncbi.nlm.nih.gov/pubmed/37602656 http://dx.doi.org/10.1002/cam4.6286 |
Ejemplares similares
-
Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives
por: Yang, Chaogang, et al.
Publicado: (2019) -
An enzymatic on/off switch‐mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA
por: Wang, Qing‐lin, et al.
Publicado: (2020) -
Management of Gastrointestinal Neuroendocrine Tumors
por: Wang, Rongzhi, et al.
Publicado: (2019) -
The value of circulating tumor cells with positive centromere probe 8 in the diagnosis of small pulmonary nodules
por: Liu, Caidong, et al.
Publicado: (2021) -
Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting
por: Zhang, Qiang, et al.
Publicado: (2020)